USAID Act To End NTDs Lymphatic Filariasis Workshop: Improving Disease Specific Assessment

''

Out of the 691 health districts (HDs) endemic for lymphatic filariasis (LF) at baseline in the Act | West portfolio, 469 (67.9%) HDs have achieved the World Health Organization's (WHO) criteria for stopping mass drug administration (MDA). In FY2020, 138 disease-specific assessments (DSAs) will be conducted involving 183 HDs in 10 countries. Out of the 222 HDs that have not achieved the WHO criteria for stopping MDA, 41 (18.1%) HDs in five countries (Benin, Burkina Faso, Ghana, Niger and Sierra Leone) represent challenging settings for LF elimination with persistent transmission due to factors including high baseline prevalence, low treatment coverage, unstable populations and cross-border movements. Twenty-six hotspot HDs will be conducting pre-transmission assessment surveys (pre-TAS) for a second, third or fourth time in FY2020. Similar challenges are reported in Act | East countries in Africa (Nigeria, Ethiopia, Uganda and Tanzania). While the programs will be working with country NTD programs to implement additional strategies aimed at ensuring high coverage for all MDAs, it is equally important to take steps to ensure that DSAs conducted in all countries follow WHO guidelines, conform to highest quality standards and take into consideration best practices and recommendation available now.  

 

Photo Gallery: 

''
Photo Credit: Act | West 
''
Photo Credit: Act | West 
''
Photo Credit: Act | West 
''
Photo Credit: Act | West 
''
Photo Credit: Act | West